PACK IN HAND · ONE-PAGE CHECK
Medicine pack check sheet
Print this sheet or fill it in before speaking with a pharmacist or clinician. Copy only what is printed on the pack in hand. The published fields below are starting points from this record, not proof that your pack is the same product.
Published record starting point
- Record display name
- TRICOR
- Generic name / active ingredient
- fenofibrate tablets
- Dosage-form class
- Fenofibrate oral tablets: 48 mg yellow unscored tablet imprinted FI and 145 mg white unscored tablet imprinted FO; two historical 90-tablet bottles
- Route
- Oral
- Record reviewed
- 2026-08-30
Copy from the pack in hand
Source-linked reading points
- 48 mg and 145 mg are labelled fenofibrate amounts per tablet. '90 Tablets' is the bottle count, not 90 tablets per dose, and 145 does not permit self-assembling three 48 mg tablets.
- The 2025 label says swallow whole and not to crush, break, dissolve or chew. Both tablets are unscored. If swallowing is difficult or a strength change is considered, ask the pharmacist or prescriber to review another appropriate product.
- The label bases geriatric dosage selection on kidney function. Age 65 or older, renal impairment, uncontrolled hypothyroidism, and use with a statin or colchicine require priority review of myopathy and rhabdomyolysis risk. Do not self-stop or self-add from the page.
- Coumarin anticoagulants such as warfarin, immunosuppressants, potentially nephrotoxic medicines and bile-acid resins belong on the review list. Unexplained muscle pain/weakness with fever or malaise, dark urine, jaundice, swelling of the face/lips/tongue/throat or breathing trouble requires prompt medical contact; severe acute features require local emergency care.
Reviewed presentation examples — compare every field
- Fenofibrate 48 mg per tablet; 90-tablet bottle; U.S. brand listing discontinuedNDC 0074-3173-90
- Fenofibrate 145 mg per tablet; 90-tablet bottle; U.S. brand listing discontinuedNDC 0074-3189-90